n-methyl-3,4-methylenedioxyamphetamine and atropine

n-methyl-3,4-methylenedioxyamphetamine has been researched along with atropine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CastaƱeda, E; Robinson, TE; Whishaw, IQ1
Badon, LA; Hicks, A; Lord, K; Meleg-Smith, S; Ogden, BA; Varner, KJ1
Lettfuss, NY; Seeger-Armbruster, S; von Ameln-Mayerhofer, A1

Other Studies

3 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and atropine

ArticleYear
Effects of cortical serotonin depletion induced by 3,4-methylenedioxymethamphetamine (MDMA) on behavior, before and after additional cholinergic blockade.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 8, Issue:1

    Topics: 3,4-Methylenedioxyamphetamine; Animals; Atropine; Behavior, Animal; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prosencephalon; Random Allocation; Rats; Rats, Sprague-Dawley; Serotonin

1993
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy.
    The Journal of pharmacology and experimental therapeutics, 2002, Volume: 302, Issue:3

    Topics: Acetylcholine; Animals; Atropine; Blood Pressure; Drug Interactions; Electrocardiography; Hallucinogens; Heart Diseases; Heart Rate; Hemodynamics; Injections, Intravenous; Male; Muscarinic Antagonists; Myocardium; N-Methyl-3,4-methylenedioxyamphetamine; Nitroprusside; Phenylephrine; Rats; Rats, Sprague-Dawley; Substance-Related Disorders; Telemetry; Vasoconstrictor Agents; Vasodilator Agents

2002
Is behavioral sensitization to 3,4-methylenedioxymethamphetamine (MDMA) mediated in part by cholinergic receptors?
    Behavioural brain research, 2013, May-01, Volume: 244

    Topics: Animals; Atropine; Central Nervous System Sensitization; Male; Mecamylamine; Motor Activity; Muscarinic Antagonists; N-Methyl-3,4-methylenedioxyamphetamine; Nicotinic Antagonists; Rats; Receptors, Muscarinic

2013